| RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation RA Jones, TJ Robinson, JC Liu, M Shrestha, V Voisin, YJ Ju, PED Chung, ... The Journal of clinical investigation 126 (10), 3739-3757, 2016 | 137 | 2016 |
| RB1 and p53 at the crossroad of EMT and triple-negative breast cancer Z Jiang, R Jones, JC Liu, T Deng, T Robinson, PED Chung, S Wang, ... Cell cycle 10 (10), 1563-1570, 2011 | 128 | 2011 |
| Mitochondrial OXPHOS induced by RB1 deficiency in breast cancer: implications for anabolic metabolism, stemness, and metastasis E Zacksenhaus, M Shrestha, JC Liu, I Vorobieva, PED Chung, YJ Ju, ... Trends in cancer 3 (11), 768-779, 2017 | 127 | 2017 |
| Cdh1 and Pik3ca mutations cooperate to induce immune-related invasive lobular carcinoma of the breast Y An, JR Adams, DP Hollern, A Zhao, SG Chang, MS Gams, PED Chung, ... Cell reports 25 (3), 702-714. e6, 2018 | 61 | 2018 |
| Recent acquisition of imprinting at the rodent Sfmbt2 locus correlates with insertion of a large block of miRNAs Q Wang, J Chow, J Hong, AF Smith, C Moreno, P Seaby, P Vrana, K Miri, ... BMC genomics 12, 1-11, 2011 | 61 | 2011 |
| shRNA Kinome Screen Identifies TBK1 as a Therapeutic Target for HER2+ Breast Cancer T Deng, JC Liu, PED Chung, D Uehling, A Aman, B Joseph, T Ketela, ... Cancer research 74 (7), 2119-2130, 2014 | 50 | 2014 |
| Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy PED Chung, DMA Gendoo, R Ghanbari-Azarnier, JC Liu, Z Jiang, J Tsui, ... Nature communications 11 (1), 1825, 2020 | 32 | 2020 |
| Targeting HER2+ breast cancer: the TBK1/IKKε axis Z Jiang, JC Liu, PED Chung, SE Egan, E Zacksenhaus Oncoscience 1 (2), 180, 2014 | 27 | 2014 |
| Novel racemosin B derivatives as new therapeutic agents for aggressive breast cancer X Xiao, M Xu, C Yang, Y Yao, L Liang, PED Chung, Q Long, ... Bioorganic & Medicinal Chemistry 26 (23-24), 6096-6104, 2018 | 19 | 2018 |
| Hypophosphorylated pRb knock‐in mice exhibit hallmarks of aging and vitamin C‐preventable diabetes Z Jiang, H Li, SA Schroer, V Voisin, YJ Ju, M Pacal, N Erdmann, W Shi, ... The EMBO Journal 41 (4), e106825, 2022 | 16 | 2022 |
| CDC25 as a common therapeutic target for triple-negative breast cancer-the challenges ahead E Zacksenhaus, JC Liu, L Granieri, I Vorobieva, DY Wang, ... Molecular & cellular oncology 5 (4), e1481814, 2018 | 15 | 2018 |
| Virally encoded connectivity transgenic overlay RNA sequencing (VECTORseq) defines projection neurons involved in sensorimotor integration V Cheung, P Chung, M Bjorni, VA Shvareva, YC Lopez, EH Feinberg Cell reports 37 (12), 2021 | 10 | 2021 |
| A racemosin B derivative, C25, suppresses breast cancer growth via lysosomal membrane permeabilization and inhibition of autophagic flux X Xiao, PED Chung, M Xu, A Hu, Y Ju, X Yang, J Song, J Song, C Wang, ... Biochemical Pharmacology 201, 115060, 2022 | 3 | 2022 |
| KNP-301, a dual inhibitor of the complement pathway and angiogenesis, effectively suppresses angiogenesis and atrophy EDP Chung, D Kim, S Ryu, J Chang, BC Lee Investigative Ophthalmology & Visual Science 62 (8), 183-183, 2021 | 3 | 2021 |
| Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer Z Jiang, YJ Ju, A Ali, PED Chung, P Skowron, DY Wang, M Shrestha, H Li, ... Nature communications 14 (1), 4313, 2023 | 1 | 2023 |
| A temporal in vivo catalog of chromatin accessibility and expression profiles in pineoblastoma reveals a prevalent role for repressor elements S Idriss, M Hallal, A El-Kurdi, H Zalzali, I El-Rassi, EA Ehli, CM Davis, ... Genome Research 33 (2), 269-282, 2023 | 1 | 2023 |
| Thinking (Metastasis) outside the (Primary Tumor) Box Z Jiang, YJ Ju, A Ali, PED Chung, DY Wang, JC Liu, H Li, I Vorobieva, ... Cancers 15 (22), 5315, 2023 | | 2023 |
| Transcriptional profiling of mouse projection neurons with VECTORseq V Cheung, P Chung, EH Feinberg STAR protocols 3 (3), 101625, 2022 | | 2022 |
| Methylation data of mouse Rb-deficient pineoblastoma PED Chung, E Zacksenhaus Data in Brief 32, 106229, 2020 | | 2020 |
| CDC25 as a common therapeutic target for triple-negative breast cancer-the challenges ahead RGA Wang, H Li, A Ali, PED Chung, YJ Ju, Z Jiang, M Shrestha | | 2018 |
